Join
Live feed
·
INSIDERFilingvia Quantisnow
C4 Therapeutics Inc. logo

Chief People Officer Schick Kelly converted options into 25,950 shares, covered exercise/tax liability with 9,004 shares and was granted 200,000 shares, increasing direct ownership by 175% to 299,881 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CCCC (C4 Therapeutics Inc.) and more on Quantisnow.